Dual Energy X-ray Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)
Status: | Active, not recruiting |
---|---|
Conditions: | Arthritis, Osteoarthritis (OA), Orthopedic, Orthopedic |
Therapuetic Areas: | Rheumatology, Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 20 - 80 |
Updated: | 12/15/2017 |
Start Date: | December 2008 |
End Date: | December 2018 |
A Dual Energy X-Ray Absorptiometry Comparison Of Periprosthetic Bone Loss Between Patients Undergoing Hip Resurfacing Surgery And Total Hip Arthroplasty
This study compares the change (loss) of bone mineral density (BMD) that occurs in the
proximal femur after hip resurfacing and total hip replacement.
proximal femur after hip resurfacing and total hip replacement.
This study compares the change (loss) of bone mineral density (BMD) that occurs in the
proximal femur after hip resurfacing and total hip replacement. The goal is to evaluate the
bone loss in the proximal femur resulting from hip resurfacing surgery and to compare this to
the bone loss in the proximal femur resulting from total hip arthroplasty.
proximal femur after hip resurfacing and total hip replacement. The goal is to evaluate the
bone loss in the proximal femur resulting from hip resurfacing surgery and to compare this to
the bone loss in the proximal femur resulting from total hip arthroplasty.
Inclusion Criteria:
- Age of at least 20 years
- Osteoarthritis
- Elective Total Hip Arthroplasty / Resurfacing
- Signed Informed Consent
Exclusion Criteria:
- Osteoporosis
- Revisions
- Femoral dysplasia
- Trochanteric osteotomy
- Inflammatory arthritis
- Breast-feeding, pregnancy, or women of child-bearing potential without documentation
of a negative pregnancy test and not utilizing contraception
- Patients with a history of having taken or currently taking PTH, fluoride therapy or
strontium ranelate or patients taking other chronic medications that in the
Investigator's opinion are known to affect bone mineral density in a substantial way
- Patients with severe medical condition(s) that in the view of the Investigator
prohibits participation in the study
- Use of any other investigational agent in the last 30 days
We found this trial at
1
site
Click here to add this to my saved trials